It gave a count of "322 dead, including 54 children, 82 women and dozens of rebels, as well as 16 unidentified bodies."
Hours earlier, medical charity Doctors Without Borders (MSF) said 355 people had died after around 3,600 patients displaying "neurotoxic symptoms" flooded into three Syrian hospitals on Wednesday, the day of the alleged attacks.
The victims all arrived within less than three hours of each other, and MSF director of operations Bart Janssens said the pattern of events and the reported symptoms "strongly indicate mass exposure to a neurotoxic agent".
Syrian opposition groups have accused President Bashar al-Assad's forces of launching massive chemical attacks near Damascus on August 21 and killing as many as 1,300 people.
The Syrian government has strongly denied those allegations, but has yet to accede to demands that UN inspectors already in the country be allowed to visit the sites.
There has been no independent verification of the number of dead, and the medical humanitarian organisation was the first independent source to report such a high toll.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
